glp-1 cancer reduction Could medications help slow progression? A new Cleveland Clinic study found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to The Impact and Safety of
Description
No correlation between insulin and islet amyloid polypeptide after stimulation with glucagon-like peptide-1 in type 2 diabetes

Patients experiencing nausea may benefit from eating smaller, more frequent meals rather than large portions, as the medication already slows stomach emptying

Additionally, make sure they offer alternative weight management medications/ solutions and can guide members who dont qualify for a GLP-1 toward other options
.png?w=1536&max-h=2752&fit=crop&auto=format)
were supported by the grants from the Cancer Prevention and Research Institute of Texas (RP220032, RP150551, and 632 RP190561) and the Welch Foundation (AU-0042-20030616)

KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease

Safety considerations hinge on formulation quality, sourcing practices, sterile compounding standards, and appropriate clinical oversight
